*	OR T2 T4 T3
R1	AND Arg1:T1 Arg2:T2	
*	OR T6 T9 T8 T7 T10
R2	Has_temporal Arg1:T6 Arg2:T11	
*	OR T13 T14
*	OR T15 T16
R3	AND Arg1:T17 Arg2:T18	
*	OR T19 T22 T21 T20 T23
R4	Subsumes Arg1:T17 Arg2:T19	
*	OR T25 T26
R5	Has_temporal Arg1:T26 Arg2:T27	
R6	AND Arg1:T28 Arg2:T29	
R7	Has_multiplier Arg1:T31 Arg2:T30	
*	OR T32 T33 T34
R8	Subsumes Arg1:T31 Arg2:T32	
*	OR T28 T31
T1	Condition 6 22	hypersensitivity
T2	Drug 26 38	tetracycline
T3	Drug 40 51	doxycycline
T4	Drug 55 67	azithromycin
T6	Drug 87 98	doxycycline
T7	Drug 100 112	azithromycin
T8	Drug 114 129	chloramphenicol
T9	Drug 131 141	rifampicin
T10	Drug 146 158	tetracycline
T11	Temporal 159 186	during the preceding 7 days
T13	Condition 188 197	Pregnancy
T14	Observation 201 215	breast-feeding
T15	Condition 231 248	myasthenia gravis
T16	Condition 252 280	systemic lupus erythematosus
T17	Condition 311 320	infection
T18	Procedure 322 337	diagnostic test
T19	Condition 353 366	acute malaria
T20	Condition 368 374	dengue
T21	Condition 376 389	leptospirosis
T22	Condition 391 398	typhoid
T23	Condition 400 421	Japanese encephalitis
T25	Condition 436 438	TB
T26	Procedure 442 454	TB treatment
T27	Temporal 455 468	in = 6 months
T28	Procedure 529 534	HAART
T29	Condition 543 546	HIV
T30	Multiplier 548 561	long term use
T31	Drug 565 583	immunosuppressants
T32	Drug 590 598	steroids
T33	Drug 600 612	chemotherapy
T34	Drug 614 628	TNF-inhibitors
T36	Non-representable 650 900	Patients with severe disease whom the clinical team feel their condition necessitates the need for additional scrub typhus treatment beyond the allocated antibiotic treatment assigned at randomization (e.g. IV chloramphenicol and/or PO/NG rifampicin)
